Remove 2020 Remove Competition Remove Healthcare Provider Remove Networking
article thumbnail

Is Medical Sales Still A Lucrative Job?

Contrarian Sales Techniques

According to data from the Bureau of Labor Statistics, the median annual salary for medical and pharmaceutical sales representatives in 2020 was $71,840. Additionally, the use of technology is also making it easier for healthcare providers to access the information they need without meeting face to face with a sales representative.

article thumbnail

What health plans should know about healthcare price transparency

Clarify Health

The No Surprises Act and Transparency in Coverage Rule The past two years have been monumental for healthcare transparency and reporting regulations. The No Surprises Act (NSA), signed into law in December 2020, and the Transparency in Coverage Rule (TiC), published in October 2020, will have significant implications for health plans in 2022.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Integrating Digital Marketing in Pharmaceutical Industry: Unlocking New Opportunities for Patient Outreach and Engagement

Pharma Marketing Network

Digital marketing provides a range of innovative tools and techniques for reaching and engaging patients, healthcare providers, and other key decision-makers. 2020, June 10). Please always check and confirm with your own sources, and always consult with your healthcare professional when seeking medical treatment.

article thumbnail

Navigating the requirements of the No Surprises Act: A guide for payers

Clarify Health

enacted the No Surprises Act in 2020. The rule aims to protect patients by establishing rules for out-of-network care and promoting transparency in healthcare pricing. Its provisions are designed to prevent patients from being caught off guard by exorbitant bills and provide avenues for resolving billing disputes.

article thumbnail

Nine for 2023, part three: thriving or surviving?

pharmaphorum

In this final instalment of IQVIA EMEA Thought Leadership’s Nine for 2023 three-part series, focusing on issues that will change the direction of healthcare and the pharmaceutical industry this year, three key competitive issues for pharmaceutical companies in 2023 are assessed. Medicines manufacturing is energy intensive.

article thumbnail

Five IDNs to watch in 2023

Clarivate

In a fiercely competitive U.S. healthcare provision landscape, integrated delivery networks, or IDNs, are differentiating their offerings by adding outpatient treatment centers, pursuing National Cancer Institute designations and investing in value-based care. Christopher Silva, Senior Healthcare Research Analyst.

article thumbnail

Exploring Pharmaceutical Sales Reps Salaries: A Deep Dive

Rep-Lite

As a pharmaceutical sales rep, you undergo a rigorous training program, develop strong relationships with healthcare professionals, and work tirelessly to meet sales targets. You also deal with the challenges of an ever-changing industry landscape, including stiff competition from generic drugs and strict regulation policies.